Daniel Edward Neafsey, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Plasmodium falciparum | 55 | 2023 | 1732 | 6.270 |
Why?
|
| Malaria, Falciparum | 37 | 2023 | 1077 | 4.900 |
Why?
|
| Anopheles | 20 | 2021 | 197 | 4.690 |
Why?
|
| Malaria | 22 | 2023 | 1239 | 3.780 |
Why?
|
| Genome, Insect | 10 | 2020 | 102 | 2.590 |
Why?
|
| Genome, Protozoan | 14 | 2020 | 142 | 2.480 |
Why?
|
| Malaria, Vivax | 11 | 2022 | 173 | 2.190 |
Why?
|
| Plasmodium vivax | 14 | 2022 | 208 | 1.980 |
Why?
|
| Insect Vectors | 7 | 2020 | 134 | 1.820 |
Why?
|
| Antimalarials | 15 | 2023 | 905 | 1.720 |
Why?
|
| Evolution, Molecular | 16 | 2018 | 1939 | 1.620 |
Why?
|
| Selection, Genetic | 15 | 2016 | 914 | 1.550 |
Why?
|
| Artemisinins | 6 | 2023 | 221 | 1.550 |
Why?
|
| Drug Resistance | 16 | 2023 | 1608 | 1.480 |
Why?
|
| Malaria Vaccines | 7 | 2022 | 158 | 1.380 |
Why?
|
| Plasmodium | 4 | 2021 | 250 | 1.270 |
Why?
|
| Antigens, Protozoan | 11 | 2022 | 322 | 1.250 |
Why?
|
| Metagenomics | 6 | 2021 | 428 | 1.130 |
Why?
|
| Protozoan Proteins | 17 | 2023 | 827 | 1.080 |
Why?
|
| Cryptococcus neoformans | 4 | 2009 | 119 | 0.880 |
Why?
|
| Genes, Insect | 6 | 2021 | 268 | 0.850 |
Why?
|
| DNA, Protozoan | 7 | 2017 | 237 | 0.850 |
Why?
|
| Genes, Protozoan | 6 | 2021 | 163 | 0.840 |
Why?
|
| Aedes | 2 | 2020 | 100 | 0.830 |
Why?
|
| Genetics, Population | 8 | 2020 | 934 | 0.790 |
Why?
|
| Sequence Analysis, DNA | 15 | 2016 | 4805 | 0.780 |
Why?
|
| Gene Flow | 4 | 2020 | 79 | 0.760 |
Why?
|
| Wolbachia | 1 | 2020 | 21 | 0.750 |
Why?
|
| Tetraodontiformes | 3 | 2005 | 12 | 0.750 |
Why?
|
| Chromosome Inversion | 2 | 2020 | 127 | 0.740 |
Why?
|
| Phylogeny | 16 | 2020 | 2804 | 0.730 |
Why?
|
| Genome, Fungal | 4 | 2010 | 204 | 0.720 |
Why?
|
| Parasitemia | 3 | 2019 | 173 | 0.710 |
Why?
|
| Polymorphism, Single Nucleotide | 27 | 2021 | 15520 | 0.700 |
Why?
|
| Introns | 5 | 2009 | 992 | 0.690 |
Why?
|
| Genetic Variation | 18 | 2020 | 6542 | 0.660 |
Why?
|
| Parasitology | 1 | 2018 | 29 | 0.640 |
Why?
|
| Haploidy | 1 | 2018 | 136 | 0.630 |
Why?
|
| Genotype | 16 | 2018 | 12952 | 0.620 |
Why?
|
| Antibodies, Protozoan | 9 | 2022 | 253 | 0.610 |
Why?
|
| Host-Parasite Interactions | 2 | 2018 | 295 | 0.570 |
Why?
|
| Gene Expression Regulation, Fungal | 3 | 2010 | 502 | 0.560 |
Why?
|
| Parasites | 5 | 2022 | 163 | 0.560 |
Why?
|
| Genomics | 12 | 2022 | 5717 | 0.550 |
Why?
|
| High-Throughput Nucleotide Sequencing | 4 | 2020 | 3596 | 0.540 |
Why?
|
| Gene Frequency | 10 | 2022 | 3587 | 0.540 |
Why?
|
| Y Chromosome | 1 | 2016 | 206 | 0.510 |
Why?
|
| DNA Transposable Elements | 3 | 2010 | 748 | 0.510 |
Why?
|
| Haplotypes | 5 | 2020 | 2779 | 0.490 |
Why?
|
| Communicable Diseases | 2 | 2022 | 880 | 0.470 |
Why?
|
| Coccidioides | 2 | 2010 | 17 | 0.460 |
Why?
|
| Biological Evolution | 4 | 2019 | 1077 | 0.460 |
Why?
|
| Cryptococcus | 4 | 2009 | 29 | 0.430 |
Why?
|
| Burkina Faso | 3 | 2020 | 88 | 0.410 |
Why?
|
| Drosophila | 4 | 2014 | 1491 | 0.400 |
Why?
|
| Hybridization, Genetic | 1 | 2010 | 109 | 0.370 |
Why?
|
| Open Reading Frames | 3 | 2009 | 811 | 0.360 |
Why?
|
| Animals | 51 | 2022 | 168770 | 0.350 |
Why?
|
| DNA Barcoding, Taxonomic | 4 | 2020 | 136 | 0.340 |
Why?
|
| Models, Genetic | 7 | 2020 | 3493 | 0.330 |
Why?
|
| Computational Biology | 4 | 2015 | 3519 | 0.330 |
Why?
|
| Base Sequence | 13 | 2015 | 12797 | 0.330 |
Why?
|
| Codon | 2 | 2007 | 611 | 0.330 |
Why?
|
| Africa | 6 | 2020 | 672 | 0.320 |
Why?
|
| Conserved Sequence | 3 | 2007 | 1202 | 0.310 |
Why?
|
| Untranslated Regions | 1 | 2007 | 31 | 0.300 |
Why?
|
| Saccharomyces | 1 | 2007 | 65 | 0.300 |
Why?
|
| Insecticide Resistance | 3 | 2021 | 20 | 0.290 |
Why?
|
| Molecular Sequence Data | 13 | 2015 | 18111 | 0.290 |
Why?
|
| RNA, Fungal | 1 | 2007 | 164 | 0.280 |
Why?
|
| 5' Untranslated Regions | 1 | 2007 | 249 | 0.270 |
Why?
|
| Takifugu | 1 | 2005 | 7 | 0.270 |
Why?
|
| Senegal | 9 | 2020 | 294 | 0.260 |
Why?
|
| DNA, Intergenic | 1 | 2005 | 107 | 0.250 |
Why?
|
| Rod Opsins | 1 | 2005 | 111 | 0.250 |
Why?
|
| Genetic Markers | 5 | 2018 | 2634 | 0.240 |
Why?
|
| Mutation | 7 | 2020 | 29786 | 0.240 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2007 | 794 | 0.230 |
Why?
|
| Sequence Deletion | 1 | 2008 | 1526 | 0.220 |
Why?
|
| Mosquito Control | 2 | 2021 | 104 | 0.220 |
Why?
|
| Disease Vectors | 2 | 2020 | 60 | 0.220 |
Why?
|
| Sequence Alignment | 5 | 2014 | 2256 | 0.210 |
Why?
|
| Multigene Family | 3 | 2018 | 1102 | 0.210 |
Why?
|
| Genome | 5 | 2015 | 1807 | 0.200 |
Why?
|
| Monkey Diseases | 1 | 2021 | 77 | 0.200 |
Why?
|
| Oviposition | 1 | 2020 | 23 | 0.190 |
Why?
|
| Chromosomes, Insect | 3 | 2014 | 15 | 0.190 |
Why?
|
| Recombination, Genetic | 3 | 2020 | 1586 | 0.180 |
Why?
|
| Quinolines | 2 | 2023 | 732 | 0.180 |
Why?
|
| Butterflies | 1 | 2019 | 8 | 0.180 |
Why?
|
| Primaquine | 1 | 2019 | 28 | 0.180 |
Why?
|
| Models, Statistical | 1 | 2015 | 5101 | 0.180 |
Why?
|
| Linkage Disequilibrium | 5 | 2018 | 1997 | 0.180 |
Why?
|
| Sex Determination Processes | 2 | 2018 | 58 | 0.180 |
Why?
|
| Genetic Speciation | 3 | 2019 | 46 | 0.180 |
Why?
|
| Arboviruses | 1 | 2018 | 12 | 0.170 |
Why?
|
| Chloroquine | 2 | 2022 | 279 | 0.170 |
Why?
|
| Vaccines, Synthetic | 1 | 2022 | 634 | 0.170 |
Why?
|
| Insect Control | 1 | 2018 | 28 | 0.170 |
Why?
|
| Arbovirus Infections | 1 | 2018 | 20 | 0.170 |
Why?
|
| 4-Butyrolactone | 1 | 2018 | 63 | 0.160 |
Why?
|
| Humans | 56 | 2023 | 744376 | 0.160 |
Why?
|
| Alleles | 4 | 2018 | 6933 | 0.160 |
Why?
|
| Cambodia | 1 | 2018 | 191 | 0.150 |
Why?
|
| RNA Splice Sites | 2 | 2009 | 209 | 0.150 |
Why?
|
| Geography | 3 | 2020 | 669 | 0.150 |
Why?
|
| Ghana | 1 | 2018 | 284 | 0.150 |
Why?
|
| Chromosomes | 1 | 2020 | 596 | 0.140 |
Why?
|
| Genes, Fungal | 2 | 2009 | 455 | 0.140 |
Why?
|
| Immunity, Humoral | 1 | 2021 | 598 | 0.140 |
Why?
|
| Asia | 3 | 2015 | 609 | 0.140 |
Why?
|
| DNA, Algal | 1 | 2015 | 2 | 0.140 |
Why?
|
| Alveolata | 1 | 2015 | 3 | 0.140 |
Why?
|
| Plasmodium knowlesi | 1 | 2015 | 22 | 0.130 |
Why?
|
| Life Cycle Stages | 1 | 2016 | 160 | 0.130 |
Why?
|
| Genetic Techniques | 1 | 2018 | 435 | 0.130 |
Why?
|
| Azetidines | 1 | 2016 | 142 | 0.130 |
Why?
|
| Africa South of the Sahara | 1 | 2018 | 724 | 0.130 |
Why?
|
| Erythrocytes | 4 | 2019 | 2455 | 0.130 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2022 | 1837 | 0.120 |
Why?
|
| Travel | 1 | 2020 | 788 | 0.120 |
Why?
|
| Serratia Infections | 1 | 2014 | 7 | 0.120 |
Why?
|
| Genetic Drift | 1 | 2013 | 43 | 0.120 |
Why?
|
| Genetic Loci | 3 | 2012 | 2575 | 0.120 |
Why?
|
| Pregnancy Complications, Parasitic | 1 | 2013 | 54 | 0.110 |
Why?
|
| Founder Effect | 1 | 2013 | 189 | 0.110 |
Why?
|
| Chromosome Mapping | 3 | 2015 | 4740 | 0.110 |
Why?
|
| Antigens, Surface | 1 | 2017 | 1663 | 0.110 |
Why?
|
| Chondroitin Sulfates | 1 | 2013 | 187 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2018 | 1152 | 0.110 |
Why?
|
| Gene Library | 1 | 2016 | 1074 | 0.110 |
Why?
|
| Piperazines | 1 | 2023 | 2488 | 0.110 |
Why?
|
| Americas | 1 | 2012 | 111 | 0.110 |
Why?
|
| Software | 2 | 2018 | 4442 | 0.100 |
Why?
|
| South America | 3 | 2022 | 181 | 0.100 |
Why?
|
| Malaria, Cerebral | 1 | 2012 | 135 | 0.090 |
Why?
|
| Pyrethrins | 2 | 2021 | 47 | 0.090 |
Why?
|
| Protein Biosynthesis | 2 | 2009 | 2126 | 0.090 |
Why?
|
| Genome-Wide Association Study | 3 | 2018 | 12262 | 0.090 |
Why?
|
| Colombia | 2 | 2020 | 258 | 0.090 |
Why?
|
| Mitosporic Fungi | 1 | 2009 | 20 | 0.090 |
Why?
|
| Mutagenesis | 2 | 2005 | 1264 | 0.090 |
Why?
|
| Microsatellite Repeats | 1 | 2012 | 802 | 0.090 |
Why?
|
| Infant | 5 | 2022 | 35134 | 0.090 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2011 | 1375 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 2015 | 1031 | 0.090 |
Why?
|
| Neurospora crassa | 1 | 2009 | 27 | 0.080 |
Why?
|
| Pyrimethamine | 1 | 2009 | 97 | 0.080 |
Why?
|
| Prevalence | 3 | 2022 | 15221 | 0.080 |
Why?
|
| DNA Fingerprinting | 1 | 2008 | 112 | 0.080 |
Why?
|
| Female | 16 | 2020 | 380200 | 0.080 |
Why?
|
| Drug Discovery | 1 | 2016 | 1058 | 0.080 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 2010 | 798 | 0.080 |
Why?
|
| Thailand | 2 | 2019 | 296 | 0.080 |
Why?
|
| Polymorphism, Genetic | 5 | 2014 | 4328 | 0.080 |
Why?
|
| Ecosystem | 1 | 2012 | 474 | 0.080 |
Why?
|
| Mutagenesis, Insertional | 1 | 2010 | 655 | 0.080 |
Why?
|
| Models, Biological | 2 | 2022 | 9584 | 0.070 |
Why?
|
| Databases, Genetic | 1 | 2014 | 1783 | 0.070 |
Why?
|
| Brazil | 2 | 2021 | 1270 | 0.070 |
Why?
|
| Receptors, Cell Surface | 1 | 2016 | 2866 | 0.070 |
Why?
|
| Child, Preschool | 6 | 2022 | 41005 | 0.070 |
Why?
|
| California | 1 | 2010 | 1402 | 0.070 |
Why?
|
| Eukaryotic Cells | 1 | 2007 | 198 | 0.070 |
Why?
|
| Principal Component Analysis | 3 | 2015 | 940 | 0.070 |
Why?
|
| Population Surveillance | 1 | 2017 | 2616 | 0.070 |
Why?
|
| Gambia | 2 | 2018 | 98 | 0.070 |
Why?
|
| Microarray Analysis | 1 | 2008 | 767 | 0.070 |
Why?
|
| Markov Chains | 2 | 2020 | 969 | 0.070 |
Why?
|
| Sri Lanka | 2 | 2020 | 90 | 0.060 |
Why?
|
| Fish Proteins | 1 | 2005 | 46 | 0.060 |
Why?
|
| International Cooperation | 1 | 2011 | 1420 | 0.060 |
Why?
|
| Species Specificity | 2 | 2009 | 2478 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 13988 | 0.060 |
Why?
|
| Placenta | 1 | 2013 | 1699 | 0.060 |
Why?
|
| Sensitivity and Specificity | 1 | 2019 | 14723 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2005 | 1085 | 0.060 |
Why?
|
| Gene Duplication | 1 | 2005 | 329 | 0.060 |
Why?
|
| Nucleic Acid Renaturation | 1 | 2003 | 11 | 0.060 |
Why?
|
| Databases, Nucleic Acid | 1 | 2004 | 211 | 0.060 |
Why?
|
| Research | 1 | 2011 | 1999 | 0.060 |
Why?
|
| Reference Standards | 2 | 2018 | 1025 | 0.050 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3037 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2008 | 1117 | 0.050 |
Why?
|
| Africa, Western | 2 | 2013 | 154 | 0.050 |
Why?
|
| RNA Splicing | 1 | 2007 | 908 | 0.050 |
Why?
|
| Mozambique | 1 | 2022 | 54 | 0.050 |
Why?
|
| Population | 2 | 2013 | 142 | 0.050 |
Why?
|
| Inhibitory Concentration 50 | 2 | 2015 | 459 | 0.050 |
Why?
|
| Biomedical Research | 1 | 2017 | 3309 | 0.050 |
Why?
|
| Adaptation, Physiological | 2 | 2020 | 1312 | 0.050 |
Why?
|
| Panama | 1 | 2020 | 30 | 0.050 |
Why?
|
| Reproduction, Asexual | 1 | 2020 | 15 | 0.050 |
Why?
|
| Male | 10 | 2019 | 350118 | 0.050 |
Why?
|
| Likelihood Functions | 1 | 2004 | 1005 | 0.050 |
Why?
|
| Gene Expression | 3 | 2015 | 7798 | 0.050 |
Why?
|
| Haplorhini | 1 | 2021 | 552 | 0.050 |
Why?
|
| Amino Acid Sequence | 3 | 2013 | 13814 | 0.050 |
Why?
|
| Guyana | 1 | 2020 | 13 | 0.050 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2005 | 2839 | 0.050 |
Why?
|
| X Chromosome | 2 | 2014 | 814 | 0.050 |
Why?
|
| Insecticides | 1 | 2021 | 195 | 0.050 |
Why?
|
| Myanmar | 1 | 2019 | 45 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2023 | 676 | 0.040 |
Why?
|
| DNA | 2 | 2005 | 7294 | 0.040 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 3647 | 0.040 |
Why?
|
| DNA Primers | 1 | 2004 | 2891 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 12073 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 2021 | 6171 | 0.040 |
Why?
|
| DNA, Mitochondrial | 1 | 2004 | 817 | 0.040 |
Why?
|
| Genetic Fitness | 1 | 2020 | 121 | 0.040 |
Why?
|
| DNA Copy Number Variations | 2 | 2018 | 1941 | 0.040 |
Why?
|
| Chromosome Deletion | 1 | 2003 | 1401 | 0.040 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2022 | 841 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2009 | 2752 | 0.040 |
Why?
|
| Tanzania | 1 | 2022 | 1346 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2023 | 63115 | 0.040 |
Why?
|
| Seasons | 2 | 2013 | 1493 | 0.040 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 2016 | 16 | 0.040 |
Why?
|
| Genetic Linkage | 2 | 2013 | 2421 | 0.040 |
Why?
|
| Dengue Virus | 1 | 2018 | 204 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2018 | 595 | 0.040 |
Why?
|
| Azabicyclo Compounds | 1 | 2016 | 68 | 0.030 |
Why?
|
| Cluster Analysis | 2 | 2014 | 2715 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2018 | 528 | 0.030 |
Why?
|
| Duffy Blood-Group System | 1 | 2016 | 58 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2019 | 1683 | 0.030 |
Why?
|
| French Guiana | 1 | 2015 | 45 | 0.030 |
Why?
|
| Recurrence | 2 | 2019 | 8340 | 0.030 |
Why?
|
| Adaptation, Biological | 1 | 2016 | 153 | 0.030 |
Why?
|
| Saimiri | 1 | 2016 | 330 | 0.030 |
Why?
|
| Uncertainty | 1 | 2020 | 735 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2007 | 5868 | 0.030 |
Why?
|
| Pupa | 1 | 2014 | 37 | 0.030 |
Why?
|
| Epitopes | 1 | 2022 | 2571 | 0.030 |
Why?
|
| Kinetics | 1 | 2003 | 6476 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2014 | 3921 | 0.030 |
Why?
|
| Serratia marcescens | 1 | 2014 | 45 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2008 | 7722 | 0.030 |
Why?
|
| Phagocytosis | 1 | 2019 | 1539 | 0.030 |
Why?
|
| Protein Array Analysis | 1 | 2015 | 411 | 0.030 |
Why?
|
| Breeding | 1 | 2013 | 51 | 0.030 |
Why?
|
| Phenylurea Compounds | 1 | 2016 | 528 | 0.030 |
Why?
|
| Cytosol | 1 | 2016 | 901 | 0.030 |
Why?
|
| Multilocus Sequence Typing | 1 | 2013 | 100 | 0.030 |
Why?
|
| Phylogeography | 1 | 2013 | 82 | 0.030 |
Why?
|
| Immune Evasion | 1 | 2016 | 360 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2019 | 1157 | 0.030 |
Why?
|
| Nucleosides | 1 | 2013 | 138 | 0.030 |
Why?
|
| Population Density | 1 | 2013 | 196 | 0.030 |
Why?
|
| Africa, Central | 1 | 2012 | 7 | 0.030 |
Why?
|
| Protein Binding | 2 | 2016 | 9384 | 0.030 |
Why?
|
| Ion Transport | 1 | 2013 | 320 | 0.030 |
Why?
|
| Uganda | 1 | 2017 | 1237 | 0.030 |
Why?
|
| Base Composition | 1 | 2012 | 293 | 0.030 |
Why?
|
| Quinazolinones | 1 | 2014 | 221 | 0.030 |
Why?
|
| Antiporters | 1 | 2013 | 277 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2019 | 2700 | 0.030 |
Why?
|
| Molecular Typing | 1 | 2012 | 106 | 0.030 |
Why?
|
| Mefloquine | 1 | 2011 | 55 | 0.020 |
Why?
|
| Safety | 1 | 2016 | 1186 | 0.020 |
Why?
|
| Adolescent | 6 | 2019 | 85784 | 0.020 |
Why?
|
| Chimera | 1 | 2013 | 485 | 0.020 |
Why?
|
| Pedigree | 1 | 2019 | 4642 | 0.020 |
Why?
|
| Phenanthrenes | 1 | 2011 | 63 | 0.020 |
Why?
|
| Malawi | 1 | 2012 | 282 | 0.020 |
Why?
|
| Ethanolamines | 1 | 2011 | 158 | 0.020 |
Why?
|
| Antibody Formation | 1 | 2015 | 1402 | 0.020 |
Why?
|
| Immunoglobulin G | 2 | 2014 | 4561 | 0.020 |
Why?
|
| Virulence | 1 | 2014 | 1333 | 0.020 |
Why?
|
| Onygenales | 1 | 2009 | 1 | 0.020 |
Why?
|
| Macaca mulatta | 1 | 2016 | 2377 | 0.020 |
Why?
|
| Fluorenes | 1 | 2011 | 160 | 0.020 |
Why?
|
| Synteny | 1 | 2009 | 79 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2007 | 7882 | 0.020 |
Why?
|
| Child | 5 | 2019 | 77708 | 0.020 |
Why?
|
| Histoplasma | 1 | 2009 | 41 | 0.020 |
Why?
|
| Young Adult | 4 | 2019 | 56434 | 0.020 |
Why?
|
| Nucleotides | 1 | 2012 | 464 | 0.020 |
Why?
|
| Blood | 1 | 2012 | 598 | 0.020 |
Why?
|
| Pan troglodytes | 1 | 2009 | 229 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2009 | 378 | 0.020 |
Why?
|
| Phenotype | 2 | 2018 | 16367 | 0.020 |
Why?
|
| Tetrahydrofolate Dehydrogenase | 1 | 2009 | 143 | 0.020 |
Why?
|
| Aspergillus | 1 | 2009 | 85 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6387 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2019 | 5974 | 0.020 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 4666 | 0.020 |
Why?
|
| Mice | 3 | 2022 | 81202 | 0.020 |
Why?
|
| Macaca | 1 | 2009 | 440 | 0.020 |
Why?
|
| DNA Repeat Expansion | 1 | 2008 | 66 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2017 | 3749 | 0.020 |
Why?
|
| Proteome | 1 | 2017 | 1798 | 0.020 |
Why?
|
| Expressed Sequence Tags | 1 | 2008 | 255 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2019 | 3589 | 0.020 |
Why?
|
| Demography | 1 | 2012 | 1656 | 0.020 |
Why?
|
| Central America | 1 | 2006 | 68 | 0.020 |
Why?
|
| Epidemics | 1 | 2013 | 523 | 0.020 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 1602 | 0.020 |
Why?
|
| Primates | 1 | 2009 | 545 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2011 | 1252 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 3848 | 0.020 |
Why?
|
| Disease Transmission, Infectious | 1 | 2011 | 547 | 0.020 |
Why?
|
| Biological Assay | 1 | 2009 | 652 | 0.020 |
Why?
|
| Environment | 1 | 2012 | 1123 | 0.020 |
Why?
|
| Piperidines | 1 | 2014 | 1602 | 0.020 |
Why?
|
| Binding Sites | 1 | 2013 | 6111 | 0.020 |
Why?
|
| Proteomics | 1 | 2017 | 3638 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 10183 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2022 | 21747 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 2887 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 3873 | 0.010 |
Why?
|
| Incidence | 1 | 2020 | 20950 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2013 | 3799 | 0.010 |
Why?
|
| Exons | 1 | 2008 | 2439 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2703 | 0.010 |
Why?
|
| Liver | 1 | 2016 | 7475 | 0.010 |
Why?
|
| Drosophila melanogaster | 1 | 2009 | 1708 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2013 | 6194 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 9445 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2007 | 4010 | 0.010 |
Why?
|
| Adult | 3 | 2019 | 214056 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2016 | 18034 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2007 | 5451 | 0.010 |
Why?
|
| Research Design | 1 | 2011 | 5986 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2017 | 23336 | 0.010 |
Why?
|
| Middle Aged | 2 | 2019 | 213388 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 18373 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 29144 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 57776 | 0.010 |
Why?
|
| Risk Factors | 1 | 2017 | 72295 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2015 | 77459 | 0.000 |
Why?
|
| Aged | 1 | 2015 | 163284 | 0.000 |
Why?
|